The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Sell Robert E since 2012.
The trader's CIK number is 1547931.
At the time of the last reporting, Sell Robert E was the Grp Chief Exec-Com, Med & Tech of Accenture Plc. (stock ticker symbol ACN).
Also see all insider trading activities at Accenture Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ACN | 0 | $0 | 7,500 | $1,184,283 | 0 | $0 |
| 2017 | ACN | 0 | $0 | 10,709 | $1,444,796 | 0 | $0 |
| 2016 | ACN | 0 | $0 | 3,848 | $457,654 | 0 | $0 |
| 2015 | ACN | 0 | $0 | 8,522 | $894,486 | 0 | $0 |
| 2014 | ACN | 0 | $0 | 13,880 | $1,099,385 | 0 | $0 |
| 2013 | ACN | 0 | $0 | 2,952 | $239,011 | 0 | $0 |
| 2012 | ACN | 0 | $0 | 2,152 | $128,711 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-07-02 | ACN | Sale | 3,750 | 162.41 | 609,026 |
| 2018-04-20 | ACN | Sale | 3,750 | 153.40 | 575,257 |
| 2017-12-26 | ACN | Sale | 3,750 | 152.92 | 573,453 |
| 2017-10-02 | ACN | Sale | 1,737 | 135.06 | 234,594 |
| 2017-06-26 | ACN | Sale | 3,000 | 123.27 | 369,810 |
| 2017-04-27 | ACN | Sale | 2,222 | 120.14 | 266,939 |
| 2016-12-23 | ACN | Sale | 2,648 | 117.64 | 311,508 |
| 2016-10-03 | ACN | Sale | 1,200 | 121.79 | 146,146 |
| 2015-11-02 | ACN | Sale | 7,064 | 107.44 | 758,934 |
| 2015-09-28 | ACN | Sale | 863 | 96.73 | 83,478 |
| 2015-01-05 | ACN | Sale | 595 | 87.52 | 52,074 |
| 2014-09-26 | ACN | Sale | 10,934 | 78.91 | 862,845 |
| 2014-07-25 | ACN | Sale | 2,946 | 80.29 | 236,540 |
| 2013-12-23 | ACN | Sale | 2,952 | 80.97 | 239,011 |
| 2012-08-02 | ACN | Sale | 2,152 | 59.81 | 128,711 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sell Robert E (Grp Chief Exec-Com, Med & Tech of Accenture Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.